FR EN

Back


13/09/2011
AM-Pharma Raises $40M Series D
AM-Pharma NV, a Dutch developer of Alkaline Phosphatase for treatment of severe inflammatory diseases, has closed on 29.2 million euro in a Series D financing round led by Ysios Capital Partners. Venture funds BB Biotech Ventures, Idinvest Partners, Forbion Capital Partners and Inventages Venture Capital also joined in on the round...
Read more on PEHub.com




X

X

X

Eurazeo

One Group, One brand

On April 28, 2021, Idinvest Partners, a wholly-owned subsidiary of Eurazeo since 2020, changed its name to reflect its integral position in the Group.
All activities in the Private Equity, Private Debt and Real Assets businesses now share the single Eurazeo brand.

Find all the information on the Group, its businesses and its commitments on the eurazeo.com website.

www.eurazeo.com